Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 449.40
Bid: 448.80
Ask: 449.40
Change: -6.80 (-1.49%)
Spread: 0.60 (0.134%)
Open: 457.00
High: 459.20
Low: 447.80
Prev. Close: 449.40
QQ. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third Quarter Trading Update

10 Feb 2016 07:00

RNS Number : 5803O
QinetiQ Group plc
10 February 2016
 

10 February 2016

 

QinetiQ Group plc

 

Third Quarter Trading Update

 

QinetiQ Group plc ('QinetiQ') today issues a third quarter trading update and reaffirms previous guidance for Group performance in the full year to 31 March 2016.

Trading Environment

The UK defence market remains uncertain. While the Government's Strategic Defence and Security Review was published in December 2015, it is likely to take some time before its impact is clear. Additionally, the Single Source Regulations Office (SSRO) is not expecting to publish the single source profit rate for the next financial year until March 2016.

EMEA Services

The performance of EMEA Services was in line with expectations in the period and revenue under contract for this financial year is as anticipated at this stage, but the division has continued to experience some de-scoping and delay to orders. During the period, EMEA Services won a contract with Motorola Solutions to provide monitoring, assessment and assurance services in support of the delivery of the UK Emergency Services Network. As announced in November 2015, it also secured a £153m five-year renewal from the UK Ministry of Defence (MOD) for aircraft engineering support.

In December, QinetiQ sold Cyveillance Inc. to Looking Glass Cyber Solutions Inc. for net disposal proceeds of £22m. Cyveillance is a former business unit of the US Services division, sold in May 2014, and more recently has been reported in EMEA Services. In the full year to 31 March 2015, it had revenues of $18m.

Global Products

Trading in Global Products was as expected during the period, and revenue under contract for this financial year is as anticipated at this stage, but its performance remains dependent on the timing and shipment of key orders in what is a shorter order cycle business.

Among the division's new orders in the period, the OptaSense business was awarded a contract to protect approximately 2,000km of pipeline which, once installed, will be the world's largest distributed fibre sensing project. The total value of the project is more than $30m of which approximately half has been contracted with OptaSense.

Outlook

Overall, the Board's expectations for Group performance in the current financial year remain unchanged from those set out in QinetiQ's interim results announcement dated 19 November 2015. ENDS

 

Notes to Editors:

QinetiQ will announce its preliminary annual results on 26 May 2016.

 

Download the QinetiQ investor relations app for iPad and iPhone from the App Store.

 

A FTSE250 company, QinetiQ uses its world class knowledge, research and innovation to provide high-end technical expertise and advice, to customers in the global aerospace, defence and security markets. QinetiQ's unique position enables it to be a trusted partner to government organisations, predominantly in the UK and the US, including defence departments as well as other international customers in targeted sectors.

For more information see www.QinetiQ.com

Follow us on twitter @QinetiQ

For further information please contact:

 

Investor relations:

David Bishop, QinetiQ

+44 (0) 7920 108675

Media relations:

QinetiQ press office

+44 (0) 1252 393500

Chris Barrie, Citigate Dewe Rogerson

+44 (0) 7968 727289

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTDKLFBQLFXBBD
Date   Source Headline
8th Feb 20187:00 amRNSThird Quarter Trading Update
22nd Jan 20183:55 pmRNSHolding(s) in Company
10th Jan 201811:08 amRNSDirector/PDMR Shareholding
12th Dec 20173:55 pmRNSDirector/PDMR Shareholding
6th Dec 201712:42 pmRNSHolding(s) in Company
20th Nov 201712:25 pmRNSDirector/PDMR Shareholding
20th Nov 201710:59 amRNSDirector/PDMR Shareholding
20th Nov 201710:53 amRNSDirector/PDMR Shareholding
16th Nov 20177:00 amRNSInterim Results
10th Nov 20173:57 pmRNSDirector/PDMR Shareholding
1st Nov 20178:19 amRNSBlock listing Interim Review
18th Oct 20174:46 pmRNSHolding(s) in Company
10th Oct 20174:03 pmRNSHolding(s) in Company
10th Oct 201712:39 pmRNSDirector/PDMR Shareholding
6th Oct 20174:35 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPre-Close Trading Statement
22nd Sep 20178:08 amRNSDirector/PDMR Shareholding
12th Sep 20172:08 pmRNSDirector/PDMR Shareholding
8th Sep 201710:43 amRNSDirector/PDMR Shareholding
5th Sep 20171:51 pmRNSHolding(s) in Company
4th Sep 20171:02 pmRNSDirector/PDMR Shareholding
4th Sep 201710:27 amRNSHolding(s) in Company
23rd Aug 201712:02 pmRNSHolding(s) in Company
22nd Aug 20174:19 pmRNSHolding(s) in Company
14th Aug 20173:52 pmRNSDirector/PDMR Shareholding
26th Jul 201712:23 pmRNSDirector/PDMR Shareholding
25th Jul 20173:43 pmRNSDirector/PDMR Shareholding
25th Jul 20179:41 amRNSDirector/PDMR Shareholding
24th Jul 20175:09 pmRNSDirector/PDMR Shareholding
24th Jul 20172:31 pmRNSDirector/PDMR Shareholding
21st Jul 201711:18 amRNSDirector/PDMR Shareholding
19th Jul 20174:05 pmRNSAGM Statement
19th Jul 20177:00 amRNSFirst Quarter Trading Update
13th Jul 20173:30 pmRNSDirector/PDMR Shareholding
11th Jul 20174:15 pmRNSDirector/PDMR Shareholding
7th Jul 20174:13 pmRNSAnnual Financial Report
23rd Jun 20179:40 amRNSDirector/PDMR Shareholding
21st Jun 20175:08 pmRNSDirector/PDMR Shareholding
13th Jun 20173:55 pmRNSAnnual Financial Report
12th Jun 20172:56 pmRNSDirector/PDMR Shareholding
25th May 20177:00 amRNSFull Year Results 2017
10th May 20174:00 pmRNSDirector/PDMR Shareholding
5th May 20174:42 pmRNSBlock listing Interim Review
12th Apr 20174:12 pmRNSDirector/PDMR Shareholding
31st Mar 20173:03 pmRNSTotal Voting Rights
28th Mar 20171:47 pmRNSTransaction in Own Shares 27 Mar 17 - Replacement
27th Mar 20175:48 pmRNSTransaction in Own Shares
24th Mar 20175:13 pmRNSTransaction in Own Shares
23rd Mar 20175:34 pmRNSTransaction in Own Shares
22nd Mar 20175:45 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.